SCHEMBL28972782

SCHEMBL28972782

CCCNCCCN1CCN(c2ccccc2OC)CC1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.76
DRD3 P35462 4/20 0.76
HTR1A P08908 3/20 0.74
CYP3A4 P08684 2/20 0.61
ADRA2A P08913 2/20 0.61
ADRA2B P18089 2/20 0.61
ADRA2C P18825 2/20 0.61
ADRA1A P35348 2/20 0.61
PMP22 Q01453 2/20 0.61
MAPT P10636 2/20 0.61
ADRA1D P25100 1/20 0.61
ADRA1B P35368 1/20 0.61
HIF1A Q16665 1/20 0.61
LMNA P02545 1/20 0.61
ADRB2 P07550 1/20 0.61
ADRB1 P08588 1/20 0.61
CYP2C9 P11712 1/20 0.61
TSHR P16473 1/20 0.61
MAPK1 P28482 1/20 0.61
SLC6A4 P31645 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10414460 0.86 DRD2 (1.00) DRD2DRD3HTR1ACYP3A4ADRA1A
SCHEMBL8577935 0.85 DRD2 (0.72) DRD2DRD3HTR1AADRA1AADRA1D
SCHEMBL13875119 0.85 HTR1A (1.00) DRD2DRD3HTR1ACYP3A4ADRA1A
SCHEMBL6526368 0.85 DRD2 (0.85) DRD2DRD3HTR1ACYP3A4ADRA1A
SCHEMBL16281735 0.84 HTR1A (0.97) DRD2DRD3HTR1ACYP3A4ADRA1A
SCHEMBL16281719 0.84 HTR1A (0.97) DRD2DRD3HTR1ACYP3A4ADRA1A
SCHEMBL16281718 0.84 HTR1A (0.97) DRD2DRD3HTR1ACYP3A4ADRA1A
SCHEMBL9567518 0.84 DRD2 (0.66) DRD2DRD3HTR1AADRA1AADRA1D
SCHEMBL31060769 0.83 DRD2 (1.00) DRD2DRD3HTR1AADRA1AADRA1D
SCHEMBL3261221 0.83 DRD2 (1.00) DRD2DRD3HTR1AADRA1AADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110511215-B Aryl piperazine/piperidine compound and application thereof 复旦大学 2023-03-28 CN disclosed